Wanbangde Pharmaceutical Holding Group 대차 대조표 상태
재무 상태 기준 확인 6/6
Wanbangde Pharmaceutical Holding Group has a total shareholder equity of CN¥2.8B and total debt of CN¥948.2M, which brings its debt-to-equity ratio to 34.3%. Its total assets and total liabilities are CN¥4.3B and CN¥1.5B respectively. Wanbangde Pharmaceutical Holding Group's EBIT is CN¥114.4M making its interest coverage ratio -31.3. It has cash and short-term investments of CN¥95.8M.
주요 정보
34.3%
부채 비율
CN¥948.22m
부채
| 이자 보상 비율 | -31.3x |
| 현금 | CN¥95.80m |
| 주식 | CN¥2.76b |
| 총 부채 | CN¥1.50b |
| 총 자산 | CN¥4.27b |
최근 재무 상태 업데이트
업데이트 없음
재무 상태 분석
단기부채: 002082's short term assets (CN¥1.7B) exceed its short term liabilities (CN¥1.3B).
장기 부채: 002082's short term assets (CN¥1.7B) exceed its long term liabilities (CN¥211.8M).
부채 대 자본 내역 및 분석
부채 수준: 002082's net debt to equity ratio (30.8%) is considered satisfactory.
부채 감소: 002082's debt to equity ratio has reduced from 66.3% to 34.3% over the past 5 years.
부채 범위: 002082's debt is well covered by operating cash flow (21.9%).
이자 보장: 002082 earns more interest than it pays, so coverage of interest payments is not a concern.